Familial Dilated Cardiomyopathy — NIH Grants & Funding

MONDO:0016333

Funding Landscape

Familial Dilated Cardiomyopathy has active NIH research funding with 9 funded grants totaling $12.6M.

9funded grants from NIH

Portfolio: $4.1MCumulative: $12.6M7 active2 completed12 PIs6 institutions

1 new grant started in the last 12 months.

By Research Theme

Basic Science

Translational

Clinical

Epi / Nat. History

Gene/Cell Therapy

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$2.7M

FY22

$3.2M

FY23

$4.1M

FY24

$2.6M

FY25

By Funding Mechanism

R01

F31

F32

Basic Science(3)

Basic ScienceR01Active

Mechanistic Basis of Cardiac Laminopathy

Gundersen, Gregg et al.·COLUMBIA UNIVERSITY HEALTH SCIENCES·NEW YORK, NY

$722,502 (FY2024)

NIH RePORTER

Basic ScienceR01Active

Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling

Wu, Joseph·STANFORD UNIVERSITY·STANFORD, CA

$675,266 (FY2025)

NIH RePORTER

Basic ScienceR01Active

Uncovering The Mechanogenomic Basis For Cardiac Plasticity

Davis, Jennifer·UNIVERSITY OF WASHINGTON·SEATTLE, WA

$651,762 (FY2025)

NIH RePORTER

Translational(3)

TranslationalR01Active

Evaluation of the AMPK-BACH1-NRF2 Axis as a Therapeutic Target for Inherited DCM

MERCOLA, MARK·STANFORD UNIVERSITY·STANFORD, CA

$602,340 (FY2025)

NIH RePORTER

TranslationalR01Active

Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine

Karakikes, Ioannis·STANFORD UNIVERSITY·STANFORD, CA

$91,843 (FY2025)

NIH RePORTER

TranslationalF32Completed

Targeting TRAPPC11 as a therapeutic in inherited dilated cardiomyopathy

Sturgill, Sarah·STANFORD UNIVERSITY·STANFORD, CA

$75,052 (FY2025)

NIH RePORTER

Clinical(1)

ClinicalR01Completed

Mechanisms and Therapeutic Targeting of DNA Damage in Dilated Cardiomyopathy Caused by LMNA Mutations

Marian, Ali·UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON·HOUSTON, TX

$483,887 (FY2023)

NIH RePORTER

Epi / Nat. History(1)

Epi / Nat. HistoryR01Completed

Defining Genetic Architecture and Pathways of DCM

CHEN, CHRISTOPHER et al.·HARVARD MEDICAL SCHOOL·BOSTON, MA

$733,383 (FY2024)

NIH RePORTER

Gene/Cell Therapy(1)

Gene/Cell TherapyF31Active

A single prime editing strategy for correcting diverse mutations responsible for RBM20-associated dilated cardiomyopathy

GASTON, NICHOLAS·UNIV OF MASSACHUSETTS MED SCH WORCESTER·WORCESTER, MA

$34,370 (FY2025)

NIH RePORTER

Top Funded Institutions

STANFORD UNIVERSITY$1.4M

CA4 grantsSturgill, Sarah, MERCOLA, MARK +2

HARVARD MEDICAL SCHOOL$733K

MA1 grantCHEN, CHRISTOPHER, SEIDMAN, CHRISTINE +1

COLUMBIA UNIVERSITY HEALTH SCIENCES$723K

NY1 grantGundersen, Gregg, Worman, Howard

UNIVERSITY OF WASHINGTON$652K

WA1 grantDavis, Jennifer

UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON$484K

TX1 grantMarian, Ali

UNIV OF MASSACHUSETTS MED SCH WORCESTER$34K

MA1 grantGASTON, NICHOLAS

Top Principal Investigators

CHEN, CHRISTOPHER$733K

HARVARD MEDICAL SCHOOL·1 grant

Epi / Nat. History

SEIDMAN, CHRISTINE$733K

HARVARD MEDICAL SCHOOL·1 grant

Epi / Nat. History

SEIDMAN, JONATHAN$733K

HARVARD MEDICAL SCHOOL·1 grant

Epi / Nat. History

Gundersen, Gregg$723K

COLUMBIA UNIVERSITY HEALTH SCIENCES·1 grant

Basic Science

Worman, Howard$723K

COLUMBIA UNIVERSITY HEALTH SCIENCES·1 grant

Basic Science

Wu, Joseph$675K

STANFORD UNIVERSITY·1 grant

Basic Science

Davis, Jennifer$652K

UNIVERSITY OF WASHINGTON·1 grant

Basic Science

MERCOLA, MARK$602K

STANFORD UNIVERSITY·1 grant

Translational

Marian, Ali$484K

UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON·1 grant

Clinical

Karakikes, Ioannis$92K

STANFORD UNIVERSITY·1 grant

Translational

Track funding opportunities for Familial Dilated Cardiomyopathy.

Follow this disease to be notified about new NIH grants and funding changes.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.